Publication: The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex
The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex
Date
Date
Date
Citations
Lorè, N. I., Saliu, F., Spitaleri, A., Schäfle, D., Nicola, F., Cirillo, D. M., & Sander, P. (2022). The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex. European Respiratory Journal, 60(6), 2201541. https://doi.org/10.1183/13993003.01541-2022
Additional indexing
Creators (Authors)
- Lorè, Nicola Ivan
- Saliu, Fabio
- Spitaleri, Andrea
- Schäfle, Daniel
- Nicola, Francesca
- Cirillo, Daniela Maria
- Sander, Peter
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Citations
Lorè, N. I., Saliu, F., Spitaleri, A., Schäfle, D., Nicola, F., Cirillo, D. M., & Sander, P. (2022). The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex. European Respiratory Journal, 60(6), 2201541. https://doi.org/10.1183/13993003.01541-2022
